tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Bod Science Reports Q1 Financials Amid Restructuring Efforts

Story Highlights
Bod Science Reports Q1 Financials Amid Restructuring Efforts

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Bod Australia Ltd ( (AU:BOD) ) just unveiled an announcement.

Bod Science Limited has reported a net cash outflow of $576k from operating activities for the quarter ending September 2025, with customer receipts totaling $540k. The company is undergoing a restructuring process under a DOCA with Biortica Agrimed Limited, which includes a Share Purchase Agreement to acquire Biortica’s shares. The completion of this process is contingent on shareholder approvals and compliance with ASX Listing Rules, with an extraordinary general meeting expected to be convened by late November 2025. This restructuring aims to stabilize Bod’s financial position and enhance its market presence.

More about Bod Australia Ltd

Bod Science Limited is a cannabis-focused distribution company based in Sydney, Australia. The company is currently operating under a Deed of Company Arrangement (DOCA) with Biortica Agrimed Limited, indicating a focus on restructuring and potential acquisition activities.

Technical Sentiment Signal: Sell

Current Market Cap: A$4.26M

For a thorough assessment of BOD stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1